findmyKOL

Raja Sivamani, MD

Enriched profile

Adjunct Associate Professor of Clinical Dermatology; Physician, Pacific Skin Institute · Pacific Skin Institute

ORCIDNPI
Region🇺🇸 Sacramento, CA · West · United StatesSpecialtyDermatologyFocusDermatology and Skin Diseases+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Raja Sivamani is Adjunct Associate Professor of Clinical Dermatology; Physician, Pacific Skin Institute at Pacific Skin Institute. OpenAlex indexes 266 publications with 6,543 citations (h-index 44); ClinicalTrials.gov lists 44 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Dermatology profiles in the findmyKOL directory.

Data verified 25 Aug 2026

Overview

Updated 27 Aug 2026

Raja Sivamani, MD, MS, AHE, is Adjunct Associate Professor of Clinical Dermatology at Pacific Skin Institute (Sacramento, CA). The public record shows 266 publications with 6,543 citations (h-index 44), centered on Dermatology and Skin Diseases, Acne and Rosacea Treatments and Effects, Skin Protection and Aging. It also documents an investigator role on 44 registered clinical trials, industry payments reported by 34 companies.

  • Top research focus: Dermatology and Skin Diseases
  • 44 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 34 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Acne / Hidradenitis12 trialsAcne Vulgaris12 trialsInflammation4 trialsAtopic Dermatitis / Eczema3 trialsRosacea3 trialsKeratosis, Actinic2 trialsKeratosis2 trialsPain2 trialsErythema2 trialsHyperpigmentation2 trialsStriae Distensae1 trialDysbiosis1 trialSkin Abnormalities1 trialSkin Diseases1 trialAcneiform Eruptions1 trialSebaceous Gland Diseases1 trialMelanosis1 trialDermatitis, Seborrheic1 trialMELAS Syndrome1 trialST Elevation Myocardial Infarction1 trialChronic Urticaria1 trialUrticaria1 trial

Research focus

OpenAlex concept fingerprint
Dermatology and Skin DiseasesAcne and Rosacea Treatments and EffectsSkin Protection and AgingAdvancements in Transdermal Drug Deliverymelanin and skin pigmentation

Drugs & molecules

across trials, industry payments and publications
Opzelurageneric · RuxolitinibClinical trialsIndustry payments204PublicationsDupixentgeneric · DupilumabClinical trialsIndustry payments189PublicationsSotyktugeneric · DeucravacitinibClinical trialsIndustry payments145Publications

Works with

trial sponsors and companies reporting payments
UCB, Inc.Clinical trialsIndustry payments295Lilly USA, LLCClinical trialsIndustry payments225Incyte CorporationClinical trialsIndustry payments207

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
266publications

Distinct works indexed by OpenAlex, matched via ORCID; 44 in PubMed.

6,543citations

Total citations across indexed works.

44h-index

Hirsch index (OpenAlex). i10-index 126.

Clinical & industry

trials, payments and federal funding
44clinical trials

Investigator role on registered studies.

View trials
34companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 44 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

34 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Dermatology

    32.5%
    Corticosteroid23.8%
    Triamcinolone acetonide86%Triamcinolone Acetonide14%
    Part D + Part B60 patients
    Interleukin-4 Receptor alpha Antagonist4.1%
    Dupixent Syringe100%
    Part D<11 patients
  • Cancer & immunology

    16%
    Porphyrin Precursor6.6%
    Aminolevulinic acid hcl100%
    Part B, office-administered21 patients
    Interleukin-17A Antagonist3.4%
    Taltz Autoinjector52%Cosentyx Sensoready (2 Pens)48%
    Part D<11 patients
  • Sensory organs

    14%
    Corticosteroid14%
    Clobetasol Propionate46%Hydrocortisone30%Betamethasone Dipropionate24%
    Part D27 patients
6 more therapeutic areas behind the reveal.Reveal →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/raja-sivamani-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • LinkedIn

    linkedin.com/in/rajasivamani

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
  • Instagram

    instagram.com/raja_sivamani

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com
1 more verified account behind the reveal.Reveal →

Mentions by others

where others cite or feature them
  • Instagram

    instagram.com/reel/DQhnyGTkswe

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • M.D.

    University of California, Davis, School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.ucdavis.edu
  • B.S.

    Bioengineering, UC Berkeley (High Honors/Magna Cum Laude)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.ucdavis.edu
  • M.S.

    Bioengineering, UC Berkeley-UCSF Joint Graduate Program

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.ucdavis.edu
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.ucdavis.edu
  • Board Certified

    American Board of Dermatology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.ucdavis.edu

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Adjunct Assistant Professor

    Department of Biological Sciences, California State University, Sacramento

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sciprofiles.com
  • Associate Professor of Dermatology

    California Northstate University College of Medicine

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →learnskin.com
  • Founder/Director

    Integrative Skin Science and Research (clinical research unit)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →a4m.com

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.